GlassScriptPhysician profile
Rafael Valencia
NPI 1366494247
$16,468.31
in general payments reported to CMS, 2019-2025
39 companies · $1,340 in 2025
The $1,340 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,492 · 2020: $2,142 · 2021: $1,355 · 2022: $1,629 · 2023: $1,534 · 2024: $1,976 · 2025: $1,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,849.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,407.39 | 2019-2020 | |
| Medtronic Vascular, INC. | $1,836.70 | 2019-2020 | |
| Amgen INC. | $1,577.54 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,341.73 | 2019-2025 | |
| Medtronic, INC. | $1,284.22 | 2021-2025 | Symplicity G3, Onyx Frontier, Hawkone |
| Janssen Pharmaceuticals, INC | $849.19 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $776.07 | 2021-2025 | Jardiance |
| Abiomed | $414.68 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $404.93 | 2022-2025 | Verquvo, Capvaxive |
| Shockwave Medical, INC | $386.54 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiva Medical, INC. | $372.81 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $259.38 | 2019-2022 | |
| Medtronic USA, INC. | $232.36 | 2019 | |
| Endologix LLC | $220.08 | 2022 | |
| Abbott Laboratories | $214.36 | 2021-2025 | Xience Skypoint |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Valencia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.